Pmlive

Pmlive PMLiVE.com is the online home to PME, Communiqué and The Directory. Sign-up for online copies: http://www.pmlive.com/register
(1)

Sign-up for online copies: http://www.pmlive.com/register

You can also find us here:
Twitter: https://twitter.com/pmlivecom
LinkedIn: https://www.linkedin.com/company/pmgroup-worldwide-ltd
Google Plus: https://plus.google.com/+pmlivecom
YouTube: https://www.youtube.com/user/PMLiVETV

The PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly p

rint titles Communiqué and The Directory are published by PMGroup. The website offers the latest pharma news, analysis, jobs and events, including the annual Pharmaceutical Market Excellence Awards (PMEAs), Communiqué Awards and the Quality in Care (QiC) Programme.

17/01/2025

More than 27,500 people worldwide are affected by the rare form of non-Hodgkin lymphoma

17/01/2025

The combination therapy has been authorised for use in adults harbouring KRAS G12C mutations

17/01/2025

The findings could pave the way for new treatment approaches that improve patient outcomes

17/01/2025

This year's Awards will take place on Friday 14 March at JW Marriott Grosvenor House in London

16/01/2025

Defining your team's purpose in a virtual setting is crucial for success. Are your workflows clear and documentation accessible? Learn how these elements can transform team dynamics and boost productivity, laying the foundation for a strong virtual workplace.

16/01/2025

Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.

16/01/2025

The drug is already approved in the US to treat ulcerative colitis, another form of inflammatory bowel disease

16/01/2025

The partners are aiming to develop new drugs for type 2 diabetes, obesity and cardiovascular disease

16/01/2025

The rare muscle-wasting disorder affects approximately 2,500 males in the UK at any one time

15/01/2025

By Lauren Vosseller and Alison Dufour

15/01/2025

SIM0500 is in phase 1 development for patients with relapsed or refractory cases of the blood cancer

15/01/2025

The injection process for subcutaneous Leqembi is expected to take an average of 15 seconds

15/01/2025

Approximately 1.8 million cases of cutaneous squamous cell carcinoma are diagnosed in the US every year

15/01/2025

In a rapidly evolving industry, staying ahead means embracing new tools thoughtfully. We're setting the gold standard by ethically leveraging AI to drive innovation while ensuring patient trust and regulatory compliance remain top priorities.

15/01/2025

In her first Ask Alex article of the year, Scientific Director, Dr Alexandra Loveday explores the ways our expert writers combine rigorous scientific data with empathetic and engaging content to create campaigns with real-world impact.

15/01/2025

In her latest Ask Alex article, Principal Medical Writer, Dr Alexandra Loveday explores modular content and whether it holds the secret to smarter and more effective medical communications. As healthcare providers and patients increasingly engage with brands across multiple digital and physical plat...

14/01/2025

The deal gives the company access to a range of central nervous system disorder drugs

14/01/2025

STX-478 is in phase 1/2 development for breast cancer and other advanced solid tumours

Address

Leatherhead
KT233JG

Opening Hours

Monday 9:30am - 5:30pm
Tuesday 9:30am - 5:30pm
Wednesday 9:30am - 5:30pm
Thursday 9:30am - 5:30pm
Friday 9:30am - 5:30pm

Website

Alerts

Be the first to know and let us send you an email when Pmlive posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category